Exploring the Role of Brainomix E-Lung Imaging Biomarkers in the Evaluation of Interstitial Lung Disease
Time: 11:45 am
day: Day One Track B AM
Details:
• Evaluating the ability for AI powered CT based biomarkers to identify patients at risk of future disease progression from a baseline CT scan
• Assessing the sensitivity of quantitative e-Lung CT biomarkers to treatment efficacy and progressive pulmonary fibrosis
• Opportunity for e-Lung biomarkers to improve clinical trial design and Real-World clinical practice